With a $50 million initial investment from Flagship, Terrana will use RNA from benign plant viruses as a chassis to carry ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

Terrana is aiming to have commercially available products in the next few years, pending regulatory approval, that can be applied as sprayables or seed treatments. And the company says its RNA-based ...

Ranjan Narula and Shakti Priyan Nair of RNA, Technology and IP Attorneys examine how Indian law and recent court rulings have ...

A University of California, Riverside-led team has made an advance in the basic understanding of Plasmodium falciparum, the ...

Terrana Biosciences will develop crop protection inputs using RNA technology, which was used by Flagship portfolio company Moderna to develop its covid-19 vaccine.

AbbVie gains control of an in vivo CAR-T therapy that could overcome limitations with currently approved autologous ...

MIT has developed a DNA sensor that can detect HPV and HIV infections through voltage changes. The sensor is durable and ...

Using an inexpensive electrode coated with DNA, MIT researchers have designed disposable diagnostics that could be adapted to detect a variety of diseases, including cancer or infectious diseases such ...

The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component of this system are pattern recognition receptors, which recognize non-self ...